Compile Data Set for Download or QSAR
maximum 50k data
Found 79 Enz. Inhib. hit(s) with all data for entry = 9065
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50190100(CHEMBL3827123 | US10618914, Compound 26 | US111112...)
Affinity DataIC50:  2.20E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189972(CHEMBL3828048 | US10618914, Compound 21 | US111112...)
Affinity DataIC50:  3.40E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189973(CHEMBL3827771 | US10618914, Compound 22 | US111112...)
Affinity DataIC50:  3.80E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438792(US10618914, Compound 27)
Affinity DataIC50:  4.10E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189974(CHEMBL3828152 | US10618914, Compound 23 | US111112...)
Affinity DataIC50:  4.20E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189986(CHEMBL3827273 | US10618914, Compound 25 | US111112...)
Affinity DataIC50:  4.40E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438793(US10618914, Compound 28)
Affinity DataIC50:  5.10E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438758(US10618914, Compound UPCDC10305 | US11111253, Comp...)
Affinity DataIC50:  5.14E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438788(US10618914, Compound 24-1 | US11111253, Compound 2...)
Affinity DataIC50:  5.72E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189922(CHEMBL1527817 | US10618914, Compound 1a | US111112...)
Affinity DataIC50:  6.80E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189923(CHEMBL3828058 | US10618914, Compound 1b | US111112...)
Affinity DataIC50:  6.80E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438757(US10618914, Compound UPCDC10281 | US11111253, Comp...)
Affinity DataIC50:  7.21E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438794(US10618914, Compound 29)
Affinity DataIC50:  7.50E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189952(CHEMBL3827948 | US10618914, Compound 19 | US111112...)
Affinity DataIC50:  8.20E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50190100(CHEMBL3827123 | US10618914, Compound 26 | US111112...)
Affinity DataIC50:  8.47E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189953(CHEMBL3827821 | US10618914, Compound 20 | US111112...)
Affinity DataIC50:  8.78E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189953(CHEMBL3827821 | US10618914, Compound 20 | US111112...)
Affinity DataIC50:  9.10E+3nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189934(CHEMBL3828691 | US10618914, Compound 10b | US11111...)
Affinity DataIC50:  1.10E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189933(CHEMBL3828202 | US10618914, Compound 10a | US11111...)
Affinity DataIC50:  1.10E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189975(CHEMBL3828160 | US10618914, Compound 24 | US111112...)
Affinity DataIC50:  1.14E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438760(US10618914, Compound UPCDC10332 | US11111253, Comp...)
Affinity DataIC50:  1.43E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189972(CHEMBL3828048 | US10618914, Compound 21 | US111112...)
Affinity DataIC50:  1.50E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438752(US10618914, Compound UPCDC10073 | US11111253, Comp...)
Affinity DataIC50:  1.70E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438789(US10618914, Compound 24-2)
Affinity DataIC50:  1.73E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189929(CHEMBL3827328 | US10618914, Compound 8a | US111112...)
Affinity DataIC50:  1.79E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189930(CHEMBL3828475 | US10618914, Compound 8b | US111112...)
Affinity DataIC50:  1.79E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50190106(CHEMBL3827607 | US10618914, Compound 32 | US111112...)
Affinity DataIC50:  1.86E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50190104(CHEMBL3828053 | US10618914, Compound 30 | US111112...)
Affinity DataIC50: >2.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189925(CHEMBL3828538 | US10618914, Compound 6a | US111112...)
Affinity DataIC50:  2.12E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189927(CHEMBL1564640 | US10618914, Compound 7a | US111112...)
Affinity DataIC50:  2.12E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189926(CHEMBL3828159 | US10618914, Compound 6b | US111112...)
Affinity DataIC50:  2.12E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438769(US10618914, Compound 7b | US11111253, Compound 7b)
Affinity DataIC50:  2.12E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438753(US10618914, Compound UPCDC10084 | US11111253, Comp...)
Affinity DataIC50:  2.13E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189924(CHEMBL1342513 | US10618914, Compound 2a | US111112...)
Affinity DataIC50:  2.68E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438765(US10618914, Compound 2b | US11111253, Compound 2b)
Affinity DataIC50:  2.68E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438761(US10618914, Compound UPCDC10352 | US11111253, Comp...)
Affinity DataIC50:  2.76E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189975(CHEMBL3828160 | US10618914, Compound 24 | US111112...)
Affinity DataIC50:  2.95E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189974(CHEMBL3828152 | US10618914, Compound 23 | US111112...)
Affinity DataIC50: >3.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189973(CHEMBL3827771 | US10618914, Compound 22 | US111112...)
Affinity DataIC50: >3.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189946(CHEMBL3827868 | US10618914, Compound 13b | US11111...)
Affinity DataIC50: >3.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189945(CHEMBL3828502 | US10618914, Compound 13a | US11111...)
Affinity DataIC50: >3.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189929(CHEMBL3827328 | US10618914, Compound 8a | US111112...)
Affinity DataIC50:  3.59E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM438755(US10618914, Compound UPCDC10115 | US11111253, Comp...)
Affinity DataIC50:  3.80E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 3(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189924(CHEMBL1342513 | US10618914, Compound 2a | US111112...)
Affinity DataIC50:  4.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189929(CHEMBL3827328 | US10618914, Compound 8a | US111112...)
Affinity DataIC50:  4.06E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189930(CHEMBL3828475 | US10618914, Compound 8b | US111112...)
Affinity DataIC50:  4.06E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189926(CHEMBL3828159 | US10618914, Compound 6b | US111112...)
Affinity DataIC50: >4.59E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189925(CHEMBL3828538 | US10618914, Compound 6a | US111112...)
Affinity DataIC50: >4.59E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189922(CHEMBL1527817 | US10618914, Compound 1a | US111112...)
Affinity DataIC50: >5.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSignal transducer and activator of transcription 1-alpha/beta(Homo sapiens (Human))
University Of Pittsburgh

US Patent
LigandPNGBDBM50189923(CHEMBL3828058 | US10618914, Compound 1b | US111112...)
Affinity DataIC50: >5.00E+4nMAssay Description:Compound samples (in 3-5 mg quantities) were evaluated in a variety of assays. All compound submissions were fully characterized (1H, 13C, IR, HRMS),...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 79 total ) | Next | Last >>
Jump to: